XTANT MEDICAL HOLDINGS, INC. Revenues
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Revenues of $53.34 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-24.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2021-02-24
- XTANT MEDICAL HOLDINGS, INC. revenues for the quarter ending 2020-12-31 was $14.02M, a 17.38% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. revenues for the quarter ending 2020-09-30 was $14.02M, a 10.85% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. revenues for the quarter ending 2020-06-30 was $10.53M, a 31.05% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. revenues for the quarter ending 2020-03-31 was $14.78M, a 11.65% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. revenues for fiscal 2020 was $53.34M, a 17.54% decline from fiscal 2019.
- XTANT MEDICAL HOLDINGS, INC. revenues for fiscal 2019 was $64.68M, a 10.42% decline from fiscal 2018.
- XTANT MEDICAL HOLDINGS, INC. revenues for fiscal 2018 was $72.20M, a 12.60% decline from fiscal 2017.
- XTANT MEDICAL HOLDINGS, INC. revenues for fiscal 2017 was $82.61M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2020-12-31 | $14.02M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $28.03M derived: sum of 2 quarters · filed 2021-02-24 | $38.56M derived: sum of 3 quarters · filed 2021-02-24 | $53.34M 10-K · filed 2021-02-24 |
| 2020-09-30 | $14.02M 10-Q · filed 2020-10-29 | $24.55M derived: sum of 2 quarters · filed 2020-10-29 | $39.32M 10-Q · filed 2020-10-29 | $56.29M derived: sum of 4 quarters · filed 2021-02-24 |
| 2020-06-30 | $10.53M 10-Q · filed 2020-08-03 | $25.31M 10-Q · filed 2020-08-03 | $42.27M derived: sum of 3 quarters · filed 2021-02-24 | $57.99M derived: sum of 4 quarters · filed 2021-02-24 |
| 2020-03-31 | $14.78M 10-Q · filed 2020-05-07 | $31.74M derived: sum of 2 quarters · filed 2021-02-24 | $47.46M derived: sum of 3 quarters · filed 2021-02-24 | $62.73M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-12-31 | $16.96M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $32.69M derived: sum of 2 quarters · filed 2021-02-24 | $47.96M derived: sum of 3 quarters · filed 2021-02-24 | $64.68M 10-K · filed 2021-02-24 |
| 2019-09-30 | $15.72M 10-Q · filed 2020-10-29 | $30.99M derived: sum of 2 quarters · filed 2020-10-29 | $47.72M 10-Q · filed 2020-10-29 | $65.98M derived: sum of 4 quarters · filed 2020-10-29 |
| 2019-06-30 | $15.27M 10-Q · filed 2020-08-03 | $32.00M 10-Q · filed 2020-08-03 | $50.26M derived: sum of 3 quarters · filed 2020-08-03 | $67.53M derived: sum of 4 quarters · filed 2020-08-03 |
| 2019-03-31 | $16.73M 10-Q · filed 2020-05-07 | $34.99M derived: sum of 2 quarters · filed 2020-05-07 | $52.25M derived: sum of 3 quarters · filed 2020-05-07 | $71.00M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $18.26M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $35.53M derived: sum of 2 quarters · filed 2020-03-05 | $54.27M derived: sum of 3 quarters · filed 2020-03-05 | $72.20M 10-K · filed 2020-03-05 |
| 2018-09-30 | $17.27M 10-Q · filed 2019-11-07 | $36.01M derived: sum of 2 quarters · filed 2019-11-07 | $53.94M 10-Q · filed 2019-11-07 | $73.27M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $18.74M 10-Q · filed 2019-08-08 | $36.67M 10-Q · filed 2019-08-08 | $56.01M derived: sum of 3 quarters · filed 2019-08-08 | $75.80M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $17.93M 10-Q · filed 2019-05-15 | $37.27M derived: sum of 2 quarters · filed 2019-05-15 | $57.05M derived: sum of 3 quarters · filed 2019-05-15 | $78.46M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $19.33M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $39.12M derived: sum of 2 quarters · filed 2019-04-01 | $60.53M derived: sum of 3 quarters · filed 2019-04-01 | $82.61M 10-K · filed 2019-04-01 |
| 2017-09-30 | $19.79M 10-Q · filed 2018-11-14 | $41.20M derived: sum of 2 quarters · filed 2018-11-14 | $63.28M 10-Q · filed 2018-11-14 | |
| 2017-06-30 | $21.41M 10-Q · filed 2018-08-08 | $43.49M 10-Q · filed 2018-08-08 | ||
| 2013-09-30 | $10.50M 10-Q · filed 2013-11-14 | |||
| 2012-03-31 | $7.77M 10-Q · filed 2012-05-04 | $16.87M derived: sum of 2 quarters · filed 2012-05-04 | $24.41M derived: sum of 3 quarters · filed 2012-05-04 | $31.92M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-12-31 | $9.10M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $16.64M derived: sum of 2 quarters · filed 2012-03-29 | $24.15M derived: sum of 3 quarters · filed 2012-03-29 | $30.15M 10-K · filed 2012-03-29 |
| 2011-09-30 | $7.54M 10-Q · filed 2011-11-14 | $15.05M derived: sum of 2 quarters · filed 2011-11-14 | $21.05M 10-Q · filed 2011-11-14 | $26.34M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-06-30 | $7.51M 10-Q · filed 2011-08-15 | $13.51M 10-Q · filed 2011-08-15 | $18.80M derived: sum of 3 quarters · filed 2012-05-04 | $22.99M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-03-31 | $6.00M 10-Q · filed 2012-05-04 | $11.29M derived: sum of 2 quarters · filed 2012-05-04 | $15.48M derived: sum of 3 quarters · filed 2012-05-04 | $18.68M derived: sum of 4 quarters · filed 2012-05-04 |
| 2010-12-31 | $5.29M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $9.48M derived: sum of 2 quarters · filed 2012-03-29 | $12.68M derived: sum of 3 quarters · filed 2012-03-29 | $15.42M 10-K · filed 2012-03-29 |
| 2010-09-30 | $4.19M 10-Q · filed 2011-11-14 | $7.39M derived: sum of 2 quarters · filed 2011-11-14 | $10.13M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $3.20M 10-Q · filed 2011-08-15 | $5.94M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |